Perbedaan Organon Pharma Indonesia Tbk. dan Trisula International Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Trisula International Tbk. diperdagangkan di Rp171 (kapitalisasi pasar 534,05 M, volume 24 jam 655,5 rb). Perbedaan utamanya: Trisula International Tbk. jauh lebih besar — sekitar 5,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRIS | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 534,05 M |
Volume | — | 655,5 rb |
Lot | — | 6,56 rb |
Perputaran | — | 111,41 jt |
Harga Rata-rata | — | 169,97 |
Nilai Transaksi | — | 111,41 jt |
Harga Ekuilibrium Indikatif | — | 171 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Trisula International Tbk was established under the name of PT Transindo Global Fashion based on Notarial Deed No. 38 dated 13 December 2004 in conjunction with Notarial Deed No. 26 dated 15 February 2005, both of Achmad Bajumi, S.H., notary in Jakarta.
Selengkapnya di halaman TRIS →